K Kamiya1, K Shimizu, A Igarashi, D Aizawa, T Ikeda. 1. Department of Ophthalmology, University of Kitasato School of Medicine, Sagamihara, Kanagawa, Japan. kamiyak-tky@umin.ac.jp
Abstract
PURPOSE: To assess the clinical outcomes and patient satisfaction after simultaneous Implantable Collamer Lens (ICL) removal and phacoemulsification with intraocular lens (IOL) implantation in ICL-implanted eyes with developing cataracts. METHODS: We retrospectively reviewed the clinical charts of 10 eyes of eight patients who developed significant cataract after ICL implantation. Patient age was 47.2+/-5.9 (mean+/-SD) years (range, 37-57 years). We determined visual acuity (log MAR), manifest refraction, endothelial cell density, and subjective satisfaction with visual outcomes measured using a visual analogue scale, that ranged from 0 (very dissatisfied) to 10 (very satisfied), before and 3 months after cataract surgery. RESULTS: Log MAR best spectacle-corrected visual acuity was significantly improved from 0.19+/-0.30 preoperatively to -0.06+/-0.07 postoperatively (P=0.007, Wilcoxon signed-rank test). Eight (80%) and nine (90%) of the 10 eyes were within 0.5 D (diopter) and 1.0 D of the targeted correction, respectively. The endothelial cell density was 2584.9+/-266.2 cells/mm(2) preoperatively, and 2340.1+/-269.7 cells/mm(2) postoperatively. The overall satisfaction with visual outcomes was scored 1.8+/-1.1 (range: 0-3) preoperatively, and 7.9+/-1.4 (range: 6-10) postoperatively. No vision-threatening complications were seen throughout the follow-up period. CONCLUSIONS: Simultaneous ICL removal and phacoemulsification with IOL implantation was safe and effective with predictable refractive results, and thus yielded a high level of patient satisfaction with ICL-induced cataract treatment.
PURPOSE: To assess the clinical outcomes and patient satisfaction after simultaneous Implantable Collamer Lens (ICL) removal and phacoemulsification with intraocular lens (IOL) implantation in ICL-implanted eyes with developing cataracts. METHODS: We retrospectively reviewed the clinical charts of 10 eyes of eight patients who developed significant cataract after ICL implantation. Patient age was 47.2+/-5.9 (mean+/-SD) years (range, 37-57 years). We determined visual acuity (log MAR), manifest refraction, endothelial cell density, and subjective satisfaction with visual outcomes measured using a visual analogue scale, that ranged from 0 (very dissatisfied) to 10 (very satisfied), before and 3 months after cataract surgery. RESULTS: Log MAR best spectacle-corrected visual acuity was significantly improved from 0.19+/-0.30 preoperatively to -0.06+/-0.07 postoperatively (P=0.007, Wilcoxon signed-rank test). Eight (80%) and nine (90%) of the 10 eyes were within 0.5 D (diopter) and 1.0 D of the targeted correction, respectively. The endothelial cell density was 2584.9+/-266.2 cells/mm(2) preoperatively, and 2340.1+/-269.7 cells/mm(2) postoperatively. The overall satisfaction with visual outcomes was scored 1.8+/-1.1 (range: 0-3) preoperatively, and 7.9+/-1.4 (range: 6-10) postoperatively. No vision-threatening complications were seen throughout the follow-up period. CONCLUSIONS: Simultaneous ICL removal and phacoemulsification with IOL implantation was safe and effective with predictable refractive results, and thus yielded a high level of patient satisfaction with ICL-induced cataract treatment.
Authors: Veronica Vargas; Jorge L Alió; Rafael I Barraquer; Justin Christopher D' Antin; Cristina García; Francisco Duch; Joan Balgos; Jorge L Alió Del Barrio Journal: Eye Vis (Lond) Date: 2020-07-01